| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
|
|
|
|||||||
|
|||||||||
Department of Pharmacology, University of Colorado Health Sciences Center, Aurora, Colorado 80045
The function of many receptors and transport proteins that reside at the surface of the cell is regulated by endocytosis and postendocytic trafficking. Modification of receptors and transporters by ubiquitin conjugation has recently emerged as the major regulatory mechanism of internalization and intracellular sorting of these membrane proteins. This review will describe recent advances in elucidating the mechanisms of ubiquitination of mammalian receptors and transporters using two examples: the receptor for epidermal growth factor and the dopamine transporter. How ubiquitination controls the endocytosis and turnover of these proteins will be also discussed.
This article has been cited by other articles:
|
|
 |
|
  S. Paiva, N. Vieira, I. Nondier, R. Haguenauer-Tsapis, M. Casal, and D. Urban-Grimal Glucose-induced Ubiquitylation and Endocytosis of the Yeast Jen1 Transporter: ROLE OF LYSINE 63-LINKED UBIQUITIN CHAINS J. Biol. Chem., July 17, 2009; 284(29): 19228 - 19236. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
E. Fernandez-Sanchez, J. Martinez-Villarreal, C. Gimenez, and F. Zafra Constitutive and Regulated Endocytosis of the Glycine Transporter GLYT1b Is Controlled by Ubiquitination J. Biol. Chem., July 17, 2009; 284(29): 19482 - 19492. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 I. J. Goldberg, R. H. Eckel, and N. A. Abumrad Regulation of fatty acid uptake into tissues: lipoprotein lipase- and CD36-mediated pathways J. Lipid Res., April 1, 2009; 50(Supplement): S86 - S90. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 T. Sorkina, T. L. Richards, A. Rao, N. R. Zahniser, and A. Sorkin Negative Regulation of Dopamine Transporter Endocytosis by Membrane-Proximal N-Terminal Residues J. Neurosci., February 4, 2009; 29(5): 1361 - 1374. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. K. Shenoy, K. Xiao, V. Venkataramanan, P. M. Snyder, N. J. Freedman, and A. M. Weissman Nedd4 Mediates Agonist-dependent Ubiquitination, Lysosomal Targeting, and Degradation of the {beta}2-Adrenergic Receptor J. Biol. Chem., August 8, 2008; 283(32): 22166 - 22176. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 Y. Tanaka, N. Tanaka, Y. Saeki, K. Tanaka, M. Murakami, T. Hirano, N. Ishii, and K. Sugamura c-Cbl-Dependent Monoubiquitination and Lysosomal Degradation of gp130 Mol. Cell. Biol., August 1, 2008; 28(15): 4805 - 4818. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. Smith, X. Su, R. El-Maghrabi, P. D. Stahl, and N. A. Abumrad Opposite Regulation of CD36 Ubiquitination by Fatty Acids and Insulin: EFFECTS ON FATTY ACID UPTAKE J. Biol. Chem., May 16, 2008; 283(20): 13578 - 13585. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 F. Huang, L. K. Goh, and A. Sorkin EGF receptor ubiquitination is not necessary for its internalization PNAS, October 23, 2007; 104(43): 16904 - 16909. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 Q. Ma Aryl Hydrocarbon Receptor Degradation-Promoting Factor (ADPF) and the Control of the Xenobiotic Response Mol. Interv., June 1, 2007; 7(3): 133 - 137. [Abstract] [Full Text] [PDF]
|
|
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| ASPET Journals | Pharmacological Reviews | Drug Metabolism and Disposition |
| Molecular Interventions | Molecular Pharmacology | J Pharmacology and Exp Therapeutics |
